Finance

Lists
524322:BOM
Kabra Drugs Ord Shs
17,68 ₹
+0,97%
(+0,17) 1D
16 қаз., 10:35:19 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524322...
Open
18,25 ₹
High
18,25 ₹
Low
17,10 ₹
Avg. vol.
71,81 мың
Volume
40,79 мың
52-wk high
35,52 ₹
52-wk low
17,00 ₹
No. of employees
31
Open
18,25 ₹
High
18,25 ₹
Low
17,10 ₹
Avg. vol.
71,81 мың
Volume
40,79 мың
52-wk high
35,52 ₹
52-wk low
17,00 ₹
No. of employees
31
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
16 минут бұрын
Why TeraWulf (WULF) Is Up 9.4% And What's Next
Traders Magazine
Traders Magazine
·
5 минут бұрын
Nasdaq Completes Acquisition of Level Markets
Investor's Business Daily
Investor's Business Daily
·
1 сағат бұрын
Futures Mixed; Anthropic Value, Tesla Roadster In Focus
About Kabra Drugs Ord Shs
CEO-
Employees31
Founded1989
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
197,64 млн
304,20 млн
354,06 млн
462,17 млн
Cost of goods sold
165,24 млн
273,24 млн
331,18 млн
430,02 млн
Cost of revenue
165,24 млн
273,24 млн
331,18 млн
430,02 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,57 млн
3,85 млн
4,49 млн
2,37 млн
Operating expense
12,14 млн
6,77 млн
9,59 млн
4,46 млн
Total operating expenses
177,38 млн
280,01 млн
340,77 млн
434,48 млн
Operating income
20,26 млн
24,19 млн
13,29 млн
27,69 млн
Other non operating income
1,79 млн
1,84 млн
-3,79 млн
765,00 м.
EBT including unusual items
22,05 млн
26,01 млн
14,15 млн
28,40 млн
EBT excluding unusual items
22,05 млн
26,01 млн
14,15 млн
28,40 млн
Income tax expense
3,68 млн
341,00 м.
3,58 млн
7,17 млн
Effective tax rate
16,70%
1,31%
25,34%
25,25%
Other operating expenses
8,45 млн
2,79 млн
4,67 млн
1,88 млн
Net income
18,37 млн
25,66 млн
10,56 млн
21,23 млн
Net profit margin
9,29%
8,44%
2,98%
4,59%
Earnings per share
-
-
-
-
Interest and investment income
-
-
4,93 млн
-
Interest expense
-
-25,00 мың
-275,00 м.
-53,00 мың
Net interest expenses
-
-25,00 мың
4,65 млн
-53,00 мың
Depreciation and amortization charges
120,00 м.
127,00 м.
430,00 м.
206,00 м.
EBITDA
20,34 млн
24,21 млн
13,38 млн
27,78 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары